Advertisement
Advertisement

HCM

HCM logo

HUTCHMED (China) Limited - ADR

14.84
USD
-0.06
-0.40%
Dec 17, 15:59 UTC -5
Closed
...

HUTCHMED (China) Limited - ADR Profile

About

HUTCHMED Limited is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED Limited, formerly known as HUTCHMED (China) Limited, is based in HONG KONG.

Info & Links

CEO

Weiguo SU

Headquarters

48TH FLOOR, CHEUNG KONG CENTER,2 QUEEN'S ROAD CENTRAL
HONG KONG, K3 , HONG KONG

Auditor

PricewaterhouseCoopers Zhong Tian LLP

Share holders

--

Employees

1,988

HUTCHMED (China) Limited - ADR Statistics

Valuation Measures

Market Capitalization2

2.59B

Enterprise Value

2.46B

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.61

Price to Cash(ytd)

24.91

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.78

52-Week Change

-17.19%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

168.04M

% Held by Insiders

3.60%

% Held by Institutions

8.82%

Balance Sheet

Total Cash(mrq)

802.45M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

82.10M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

2.68%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement